You Position: Home > Paper
Gene construction, expression and activity identification of recombinant anti-HER2 ScFv/FDT/caspase-6
( views:201, downloads:0 )
- Author:
- No author available
- Journal Title:
- JOURNAL OF THE FOURTH MILITARY MEDICAL UNIVERSITY
- Issue:
- 3
- DOI:
- 10.3321/j.issn:1000-2790.2007.03.001
- Key Word:
- ScFv抗体;caspase-6基因;细胞凋亡
Abstract： 目的:构建重组抗HER2 ScFv/FDT/caspase-6 基因的表达载体,转染SGC7901胃癌细胞后观察其促凋亡作用. 方法:采用重组PCR法,将抗HER2的单链抗体(e23sFv)通过白喉毒素的Furin识别位点的编码序列(FDT)与人重构型caspase-6(RC6)基因重组,构建融合蛋白表达基因e23sFv-FDT-RC6. 将所获得的重组基因克隆入真核表达载体pCMV,以脂质体法瞬时转染HER2阳性的SGC7901细胞和HER2阴性的HeLa细胞. MTT法检测目的基因转染后细胞的增殖情况. 间接免疫荧光染色观察目的基因的表达对SGC7901细胞的促凋亡作用. 结果:把e23sFv-RC6,e23sFv-FDT-RC6基因克隆入真核表达载体pCMV,酶切鉴定和基因测序证明目的基因序列正确. 转染SGC7901和HeLa细胞后,Western Blot检测到目的蛋白的表达. MTT实验观察到转染pCMV-e23sFv-FDT-RC6的SGC7901细胞的增殖被明显抑制,间接免疫荧光染色可以观察到表达e23sFv-FDT-RC6融合蛋白的SGC7901细胞形态发生改变,部分细胞呈现典型凋亡特征. 结论:重组抗HER2 ScFv/FDT/caspase-6基因的表达可促进HER2阳性SGC7901胃癌细胞的凋亡.
- [1]van-der-Goot FG,Schiavo G.The bacterial toxin toolkit.[J].2001,2(7).
- [2]C B, Siegall,V K, Chaudhary,D J, FitzGerald,etc.Functional analysis of domains II, Ib, and III of Pseudomonas exotoxin.[J].1989,264(24).
- [3]Dingwall C,Earnshaw WC,Ruchaud S,etc.Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation.[J].2002,21(8).
- [4]Yan-Ming Xu,Jing Zhao,Cheng-Ji Wang,etc.A Caspase-6 and Anti-Human Epidermal Growth Factor Receptor-2(HER2)Antibody Chimeric Molecule Suppresses the Growth of HER2-Overexpressing Tumors[J].2004,173(1).
- [5]Eccles SA.The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis.[J].2001,6(4).
- [6]Adrain C,Slee EA,Martin SJ.Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis.[J].2001,276(10).
- [7]D W, Nicholson.Caspase structure, proteolytic substrates, and function during apoptotic cell death.[J].1999,6(11).
- [8]Thomas G.Furin at the cutting edge: from protein traffic to embryogenesis and disease.[J].2002,3(10).
- [9]Dixit VM,Salvesen GS.Caspase activation: the induced-proximity model.[J].1999,96(20).
- [10]Castiglioni F,Agresti R,Fortis S,etc.HER2 as a prognostic factor in breast cancer.[J].2001,61(Suppl.2).
- [11]Luo Z,Alnemri ES,Huang Z,etc.Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits.[J].1998,273(17).